Eli Lilly (NYSE:LLY) announced today that it committed an additional $4.5 billion investment across certain Indiana manufacturing sites. The company’s commitment extends to two of its three locations in Lebanon, Indiana. It brings its total Indiana capital expansion commitments since 2020 to more than $21 billion. This marks the latest investment across the U.S., with the pharmaceutical giant recently announcing new sites in Pennsylvania, Virginia, Texas and Alabama.